News

As the newest member of Datatrak’s CRO Connect Program, Keypoint is able to expand its electronic data capture (EDC) capabilities and empower its staff to more efficiently manage

Dr. Smith is a distinguished clinician and research scientist, who has made major contributions to the Canadian cardiology and medical communities and, in recognition of his outstanding achievements,

Eli Lilly and Company has reported a net income of $1.31 billion, or $1.20 per share, for the first quarter of 2009, an increase of 23%, compared to

Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has initiated clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam. With these studies, Sanofi Pasteur is

Par Pharmaceutical Companies, a developer of generic drugs and branded pharmaceuticals, has entered into a settlement agreement with Reliant Pharmaceuticals, a subsidiary of GlaxoSmithKline, that resolves patent litigation

BioMarin Pharmaceutical has initiated a Phase I/II clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder mucopolysaccharidosis type IVA, or Morquio

“Our first-quarter sales growth is in line with our objectives,” commented Stéphane Bancel, bioMérieux’s chief executive officer. “In today’s difficult financial and economic climate, our product diversification, our

Novagali Pharma, a France-based ophthalmic pharmaceutical company, has successfully completed a new Phase II clinical study with Cyclokat, its formulation of cyclosporine. The results demonstrate statistically significant improvement

Medicure, a biopharmaceutical company engaged in the research, development and commercialization of novel small molecules to treat cardiovascular and neurological disorders, has reported a net loss of C$3.64m,